ArticleBMJ open respiratory research2024

High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis.

Shinichiro Miura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.